Global Hemostats Market Size study, by Product (Thrombin-Based, Oxidized Regenerated Cellulose-Based, Combination, Gelatin-Based, Collagen-Based), by Formulation (Matrix & Gel, Sheet & Pad, Sponge, Powder) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) and Regional Forecasts 2018-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Hemostats Market valued approximately USD 2.15 billion in 2017 is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2018-2025.Increasing demand for Hemostats, increasing the number of surgical procedures rising number of regulatory approvals, growing incidence of sports-related injuries and spinal ailments, and increasing effective blood loss of patients during are the major factors which are driving in the growth of the Global Hemostats Market. The increasing number of hospitals and surgical centers are anticipated for further growth in the hemostats market in upcoming period. However, increase in funding in R&D as well as advancement in technology had leaded to increase the market growth. In other word, we can say hemostats as arterial forceps or hemostatic clamp. Generally, the hemostat is a surgical tool which is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Due to the presence of a pool of patients throughout the world, Hemostats Market is tremendously growing day by day.

The market of hemostats is segmented by product, formulation, application, and region. On the basis of product, the hemostats market is classified into thrombin-based hemostats oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. With the use of thrombin-based hemostats, hemostats market is expected to its largest growth in its market share. On the basis of formulation, the hemostats market is categorized into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. The sponge hemostat is expected to dominate the demand of market share during forecast period. On the basis of application, the hemostats market is further classified into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. An increase in the number of surgeries, rise in the incidence of various diseases and increase in concern & awareness about health has turned the market growth to its extent in orthopedic surgeries.

North America contributes to market growth by applying different strategies by market players like new product launches, collaborations in order to enhance the market revenue, joint ventures, agreements and partnerships. It is expected to increase the market demand in Europe and Asia-Pacific region, while North America is leading the consumer of hemostats market.

Global Hemostats MarketThe objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose-Based Hemostats
  • Combination Hemostats
  • Gelatin-Based Hemostats
  • Collagen-Based Hemostats

By Formulation:

  • Matrix & Gel Hemostats
  • Sheet & Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

By Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others Surgery

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016

Base year – 2017

Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include C. R. Bard, B.Braun, Baxter, Integra Lifesciences, Marine Polymer Technologies, Pfizer, Gelita Medical GmbH, Z-Medica, LLC, Ethicon (Subsidiary of Johnson & Johnson), Teleflex Incorporated, CSL Behring, Cryolife, INC., B Braun Melsungen AG and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Hemostats Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.           Executive Summary

1.1.         Market Snapshot

1.2.         Key Trends

1.3.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

1.3.1.     Global Hemostats Market, by Region, 2015-2025 (USD Billion)

1.3.2.     Global Hemostats Market, by Product, 2015-2025 (USD Billion)

1.3.3.     Global Hemostats Market, by Formulation, 2015-2025 (USD Billion)

1.3.4.     Global Hemostats Market, by Application, 2015-2025 (USD Billion)

1.4.         Estimation Methodology

Chapter 2.           Global Hemostats Market Definition and Scope

2.1.         Research Objective

2.2.         Market Definition& Scope

2.2.1.     Industry Evolution

2.2.2.     Scope of the Study

2.3.         Years Considered for the Study

2.4.         Currency Conversion Rates

2.5.         Report Limitation

Chapter 3.           Global Hemostats Market Dynamics

3.1.         See Saw Analysis

3.1.1.     Market Drivers

3.1.2.     Market Challenges

3.1.3.     Market Opportunities

Chapter 4.           Global Hemostats Market Industry Analysis

4.1.         Porter’s 5 Force Model

4.1.1.     Bargaining Power of Buyers

4.1.2.     Bargaining Power of Suppliers

4.1.3.     Threat of New Entrants

4.1.4.     Threat of Substitutes

4.1.5.     Competitive Rivalry

4.1.6.     Futuristic Approach to Porter’s 5 Force Model

4.2.         PEST Analysis

4.2.1.     Political Scenario

4.2.2.     Economic Scenario

4.2.3.     Social Scenario

4.2.4.     Technological Scenario

4.3.         Value Chain Analysis

4.3.1.     Supplier

4.3.2.     Manufacturers/Service Provider

4.3.3.     Distributors

4.3.4.     End-Users

4.4.         Key Buying Criteria

4.5.         Regulatory Framework

4.6.         Cost Structure Analysis

4.6.1.     Raw Material Cost Analysis

4.6.2.     Manufacturing Cost Analysis

4.6.3.     Labour Cost Analysis

4.7.         Investment Vs Adoption Scenario

4.8.         Analyst Recommendation & Conclusion

Chapter 5.           Global Hemostats Market, By Product

5.1.         Market Snapshot

5.2.         Market Performance – Potential Model

5.3.         Global Hemostats Market, Sub Segment Analysis

5.3.1.     Thrombin-Based Hemostats

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.     Oxidized Regenerated Cellulose-Based Hemostats

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.     Combination Hemostats

5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.     Gelatin-Based Hemostats

5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.2 Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.     Collagen-Based Hemostats

5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6.           Global Hemostats Market, By Formulation

6.1.         Market Snapshot

6.2.         Market Performance – Potential Model

6.3.         Global Hemostats Market, Sub Segment Analysis

6.3.1.     Matrix & Gel Hemostats

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.     Sheet & Pad Hemostats

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.     Sponge Hemostats

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.     Powder Hemostats

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7.           Global Hemostats Market, By Application

7.1.         Market Snapshot

7.2.         Market Performance – Potential Model

7.3.         Global Hemostats Market, Sub Segment Analysis

7.3.1.     Orthopedic Surgery

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.     General Surgery

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.     Neurological Surgery

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.     Cardiovascular Surgery

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.     Reconstructive Surgery

7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.     Gynaecological Surgery

7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.     Other Surgery

7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8.           Global Hemostats Market, by Regional Analysis

8.1.         Hemostats Market, Regional Market Snapshot (2015-2025)

8.2.         North America Hemostats Market Snapshot

8.2.1.     U.S.

8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.     Canada

8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.         Europe Hemostats Market Snapshot

8.3.1.     U.K.

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.     Germany

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.     France

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.     Rest of Europe

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.         Asia Hemostats Market Snapshot

8.4.1.     China

8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.     India

8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.     Japan

8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.     Rest of Asia Pacific

8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.         Latin America Hemostats Market Snapshot

8.5.1.     Brazil

8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.     Mexico

8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.         Rest of The World

8.6.1.     South America

8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.     Middle East and Africa

8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3. Formulation breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9.           Competitive Intelligence

9.1.         Company Market Share (Subject to Data Availability)

9.2.         Top Market Strategies

9.3.         Company Profiles

9.3.1.     C. R. Bard

9.3.1.1. Overview

9.3.1.2. Financial (Subject to Data Availability)

9.3.1.3. Product Summary

9.3.1.4. Recent Developments

9.3.2.     B.Braun

9.3.3.     Baxter

9.3.4.     Integra Lifesciences

9.3.5.     Marine Polymer Technologies

9.3.6.     Pfizer

9.3.7.     Gelita Medical GmbH

9.3.8.     Z-Medica, LLC

9.3.9.     Ethicon (Subsidiary of Johnson & Johnson)

9.3.10.   Teleflex Incorporated

9.3.11.   CSL Behring

9.3.12.   Cryolife, INC.

9.3.13.   B Braun Melsungen AG

Chapter 10.         Research Process

10.1.      Research Process

10.1.1.   Data Mining

10.1.2.   Analysis

10.1.3.   Market Estimation

10.1.4.   Validation

10.1.5.   Publishing

10.1.6.   Research Assumption

The Research Methodology for Global Hemostats Market Study deeply focuses on the entire value chain of the market. However, all of the statistical estimates are purely based on the consumption/implementation side of the value chain wherein the market sizes have been calculated by analyzing the prices i.e. sale price or cost prices along with the average demand/ procedures/usage/ deployment/execution of Hemostats across various industries / end-use/applications.

The whole Hemostats industry has been divided into various segments i.e. Product, Component, Application, Vertical, End-Use and Regions and each of which is studied as an individual study by our research analysts and consultants. Each of the subsegments has been analyzed and estimated at country level to form a regional scope. After finalizing the regional and segmental revenues the total revenue for Global Hemostats Market is calculated as a sum of all the different segments.

Some of the key data points considered under the Research Methodology to calculate the revenue for Global Hemostats Market includes:

  • Revenues from key companies
  • Company market share analysis
  • Consumer spending analysis
  • Regional export and import analysis
  • Regulatory Trends
  • Sales revenue generated by various products/applications in different countries/geographies

The Research Methodology starts with extensive data mining, using paid & free authentic information sources such as white papers, industry journals, trade magazines, Hoovers, Factiva, Statista, news websites, technical publications, independent studies etc. a team of dedicated research analysts and associates work on all of the gathered data to extract relevant information. Key factors such as ongoing & upcoming industry trends, external & internal driving factors, restraining factors, growth opportunities and value chain analysis have been verified in order form qualitative part of the report and to back the estimation team for quantitative analysis.

We utilize a combination of top-down and bottom-up methodology for industry estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the estimates and forecasts through primary interviews and feedbacks. An extensive primary and secondary research have been conducted with the key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify industry trends and estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

All of the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from another. These models are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts. Both the types are used collectively in order to derive market estimates for the base year as well as for forecast period.


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…